Below are the most recent publications written about "Lung Neoplasms" by people in Profiles.
-
Sambanthamoorthy S, Ren Y, Galvez TK, King B, Liu SD, Kidd BA, Law DA, Baumgarth N. The Presence of CD11c+ B Cells with Potent Effector Memory Phenotype in Lung Adenocarcinoma Correlates with Overall Patient Survival. Cancer Immunol Res. 2026 May 04; 14(5):811-826.
-
Akinyemi O, Fasokun M, Eze A, Ugochukwu N, Arshad S, Belie O, Hughes K, Cornwell Iii E, Levy G. Association of medicaid expansion with lung cancer-specific and overall mortality: A difference-in-differences analysis. PLoS One. 2026; 21(4):e0332292.
-
Dela Cruz MC, Yao X, Nealy A, Bailey J, Nalls M, Medina PM, Chen R, Biliran H. BIT1 as an Effector of EGFR-TKI-induced Apoptosis via TLE1 Inhibition in Lung Adenocarcinoma Cells. Anticancer Res. 2026 Apr; 46(4):1799-1818.
-
Lam AC, Li Y, Brown MC, Deng Y, Hueniken K, Leighl NB, Shepherd FA, Murison K, Wang Z, Kothari J, Wenzlaff AS, Liu H, Kohno T, Pesatori AC, Harris C, Ma H, Dai J, Barnett MJ, Diver R, Leal LF, Fernandez-Tardon G, P?rez-R?os M, Davies MP, Holleczek B, Brennan P, Zaridze D, Holcatova I, Lissowska J, Swiatkowska B, Mates D, Savic M, Brenner H, Andrew AS, Taylor F, Field JK, Ruano-Ravina A, Shete SS, Tardon A, Wang Y, Marchand LL, Reis RM, Schabath MB, Neuhouser ML, Shen H, Landi MT, Shiraishi K, Zhang J, Schwartz AG, Tsao MS, Christiani DC, Yang P, Hung RJ, Xu W, Liu G. Evaluating eight smoking metrics for modelling survival in non-small cell lung cancer. Cancer Epidemiol. 2026 Jun; 102:103052.
-
Pettit NR, Hays M, Li X, Wiltshire J, Musey P. Low Cancer Screening Rates Among Emergency Department Patients: A Multicenter Retrospective Study. Cancer Invest. 2026 May; 44(5):555-558.
-
Teteh-Brooks DK, Love M, Ewing AP, Ferrell B, Okunowo O, Shin A, Erhunmwunsee L, Montgomery SB, Raz D, Kittles R, Kim JY, Sun V. Social determinants of health in lung cancer surgery: perspectives from family caregivers, clinicians, and healthcare system administrators. Front Public Health. 2025; 13:1681825.
-
Carbone M, Amos C, Attanoos RL, Boeri M, Bueno R, Bunn PA, Chirieac LR, Cooper B, Fennell D, Galateau-Salle F, Giannakou L, Goparaju CV, Hassan R, Hofman P, Kris MG, Mao W, Minaai M, Mitsudomi T, Molina TJ, Montuenga LM, Nabeshima K, Passaro A, Peters S, Rajan A, Richardson DB, Robbins H, Rolfo C, Rudin CM, Samet JM, Scherpereel A, Schrump DS, Sozzi G, Taioli E, Vison? SD, Yang H, Yoshikawa Y, Zhao A, Pass HI. Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact. J Thorac Oncol. 2026 01; 21(1):41-76.
-
Liu Y, Li Y, Byun J, Shaw VR, Pikielny C, Peng B, Cheng C, Tsavachidis S, Xiao X, Zhu D, Han Y, Gorlov IP, Gorlova OY, Cole M, Gaba CR, Crawford EL, Purrington K, Goode EL, Yang P, McKay J, Field JK, Liu G, Hung RJ, Xia J, Choi J, Schabath MB, LoPiccolo J, Christiani DC, Bailey-Wilson J, Schwartz AG, Willey JC, Mandal D, Pinney SM, Amos CI. High-Penetrance Rare Variants Underlying Familial Lung Cancer Risk: Insights From Genetic Epidemiology of Lung Cancer Consortium. J Thorac Oncol. 2026 May; 21(5):103534.
-
Castillo MB, Rankothgedera S, Thevasagayampillai S, Kandasamy A, Lewis J, Woody C, Vaz de Freitas M, Antunes DA, El-Zein R, Gunaratne PH. Identification of immunogenic KIF5B-RET fusion neopeptides driving immune stimulation in tumor specific CD8+ T cells. Front Immunol. 2025; 16:1635810.
-
Subramaniam S, Donnellan L, Wignall A, Woodcock J, Coolen C, Pitson S, Taheri A, Young C, Hoffmann P, Prestidge CA, Joyce P. Polymeric-lipid nanoparticles that leverage cationic helper lipids and the protein corona for lung-targeted delivery of a novel anti-cancer drug. J Control Release. 2025 Dec 10; 388(Pt 1):114299.